Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphoma
Eli P. Darnell(Harvard University), Marcela V. Maus(Harvard University), Trisha R. Berger(Harvard University), Justin A. Budka(Gilead Sciences (United Kingdom)), Justyna Kanska, Kathleen M.E. Gallagher(Harvard University), David J. Bozym(Massachusetts General Hospital), Tarinee Huang, Rhine Shen, Mark B. Leick(Massachusetts General Hospital), Gabriela Balderrama-Gutierrez, Irene Scarfò(Harvard University)
Cited by 4
Related Papers
Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing
|Nature Biotechnology|2019|724
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
|Science Translational Medicine|2021|257
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells
|Nucleic Acids Research|2014|123